Quality by Design (QbD) in Pharmaceutical Development - Pusuluri, Siva Krishna;Eswarudu, Munnangi Mukkanti;Shaik, Rafath Sulthana
30,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
15 °P sammeln
  • Broschiertes Buch

Quality by Design (QbD) is a systematic approach to pharmaceutical development that emphasizes building quality into a product from the outset, rather than relying solely on end-product testing. This approach involves understanding the science behind formulation and manufacturing processes, identifying critical quality attributes (CQAs), and designing processes that consistently deliver products meeting predefined quality standards. QbD integrates risk management, process optimization, and continuous improvement throughout the product lifecycle. It encourages the use of scientific knowledge,…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Quality by Design (QbD) is a systematic approach to pharmaceutical development that emphasizes building quality into a product from the outset, rather than relying solely on end-product testing. This approach involves understanding the science behind formulation and manufacturing processes, identifying critical quality attributes (CQAs), and designing processes that consistently deliver products meeting predefined quality standards. QbD integrates risk management, process optimization, and continuous improvement throughout the product lifecycle. It encourages the use of scientific knowledge, data analysis, and process control tools to enhance product quality, reduce variability, and ensure regulatory compliance. By focusing on design and process development, QbD aims to improve manufacturing efficiency as well as the safety and efficacy of pharmaceutical products.
Autorenporträt
Mr. Pusuluri Sivakrishna is an Assistant Professor in the Department of Pharmaceutical Analysis at Vignan Pharmacy College, with a total of 4 years of experience in academia. He specializes in pharmaceutical analysis, focusing on analytical techniques, quality control, and the development of new analytical methods for drug analysis.